Navigation Links
ImpactRx Acquires TargetRx
Date:9/13/2011

MOUNT LAUREL, N.J., Sept. 13, 2011 - ImpactRx, a Symphony Technology Group (STG) company and the pioneer in measuring the impact of promotion on physician prescribing behavior, announced today that it has acquired 100% of TargetRx, Inc., a leading provider of insight into the drivers of physician behavior for pharmaceutical companies, in order to combine the highly complementary capabilities of the two companies into a stronger solution offering for customers.  The new company will be known as ImpactRx and new ImpactRx President and CEO, Gregory Ellis, will lead the combined company.  Financial terms of the transaction were not disclosed.

"We are very excited to join forces with TargetRx," declared Ellis.  "In the years we spent in the marketplace together, and from the feedback we received from customers, it's clear that the capabilities of these two companies are very complementary," Ellis stated.  "ImpactRx specializes in helping clients understand the actual behavior of physicians in response to promotion, while TargetRx helps clients understand the underlying drivers of that behavior as they relate to physicians' attitudes, perceptions and beliefs," said Ellis.  "Together, we will provide our clients with an unprecedented level of insight into what physicians do and why they do it," Ellis concluded.

Since its founding in 1999, TargetRx has served a majority of the top thirty pharmaceutical and biotech companies providing them insight into the drivers of product choice and the adoption of their brands.  Powered by its unique AdvantageBuilder™ normative database and validated predictive models, TargetRx has developed proprietary analytical methodologies to provide clients critical insight into launch forecasting and positioning, physician segmentation and targeting for personal and non-personal promotion, professional marketing and message optimization, and sales and marketing execution and effectiveness.

"When we acquired ImpactRx earlier this year, our strategic intent was to build a differentiated solutions company in life sciences capable of delivering compelling value to clients through insights informed by data," said J.T. Treadwell, Managing Director with STG.  "STG has a strong history of partnering with our companies to deliver innovation and growth, and we believe the addition of the TargetRx capabilities allows us to combine unique assets and complementary approaches, analytical talent, and a strong history of joint innovation as the foundation of a world-class solutions provider," Treadwell stated.  

About ImpactRx

ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry.  Powered by the ImpactData™ generated by its longitudinal panels of more than 4,000 targeted, iPhone-connected physicians (who through its proprietary technology are the exclusive source of continuously-captured promotion and treatment data) and combined with its industry-leading analytics and custom research capabilities, ImpactRx provides clients with unprecedented insight into the drivers of physician brand choice within a complete competitive context.  These insights enable clients to improve brand performance by making more effective decisions around marketing strategy, field and channel execution and pre-launch and launch planning.  ImpactRx is a Symphony Technology Group company.  For more information, visit: www.impactrx.com.

About Symphony Technology Group

Symphony Technology Group (STG) is a strategic private equity firm with the mission of investing in and building great software and services companies. In addition to capital, STG provides transformation expertise to enable its portfolio companies to deliver maximum value to clients, to retain and attract the best talent, to drive growth through innovation, and to achieve best-in-class business performance.  STG's current portfolio consists of fourteen global companies with combined revenue of $2.5 billion and 15,000 employees spread across North America, Europe and Asia.  For more information, visit: www.symphonytg.com.

CONTACT:  
Patrick Angelastro
Senior Vice President, Strategic Development
ImpactRx, Inc.
856-802-4102
pangelastro@impactrx.com


'/>"/>
SOURCE ImpactRx
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ImpactRx Measures How Patient Brand Requests Drive Physician Treatment Decisions
2. ImpactRx Names Kjell Nygren Vice President, Analytical Services
3. ImpactRx Expands Psychiatry Research Panel to Include Adolescent Psychiatrists
4. ImpactRx Acquired by Symphony Technology Group
5. ImpactRx Releases 2010 Oncology Promotion Report
6. Kantar Health and ImpactRx Launch CancerMPact Monthly Drugs and Regimens for Oncology Business Decisions
7. ImpactRx Tracks Decline in Zetia and Vytorin Prescribing
8. Frontier Scientific Services, Inc. Acquires the Assets of ASDI, Inc.
9. MD On-Line Acquires Strategic Edge Communications, Expands Provider Offerings to Include Pharmaceuticals
10. Hill-Rom Acquires Liko France and Switzerland
11. vRad Acquires Diagnostic Imaging Inc. and Merges On-Site Radiology Practice into Growing National Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2017)... Pa. , June 19, 2017  Researchers from ... today that they will host a live, complimentary webinar ... from the benchtop to the real world" on Wednesday ... EDT. This webinar will feature interviews ... rare look into the manipulation techniques abusers use to ...
(Date:6/14/2017)... 2017  In 2016, Embodied Labs took ... competition and came away with $25,000 in seed-fund investment. ... Forbes as "entering the life of another" and by ... "empathy to medical professionals in an entirely new dimension." ... a finalist for the Department of Education,s EdSimChallenge, where ...
(Date:6/9/2017)... 2017 AirXpanders, Inc. (ASX: AXP) (AirXpanders or ... manufacture, sale and distribution of the AeroForm® Tissue Expander ... its commercial roll-out in the United States ... one hundred (100) medical institutions and health systems, located ... needle-free alternative for women who choose reconstructive surgery following ...
Breaking Medicine Technology:
(Date:6/20/2017)... ... June 20, 2017 , ... Kenneth Mayer, MD, has been appointed a new ... Mayer, who joined the JIAS Editorial Board in 2016, has co-authored more than 800 ... Fenway Health and Co-Chair of The Fenway Institute, a member of the ...
(Date:6/20/2017)... Houston, Texas (PRWEB) , ... June 20, 2017 , ... ... of their new website and a host of new options for today’s modern ... helping seniors maintain the active, independent lifestyle they love while offering them the services ...
(Date:6/20/2017)... ... June 20, 2017 , ... MindTouch , the leading ... proud to announce Touchpoints integrations. MindTouch Touchpoints easily integrate product documentation ... to provide a seamless customer experience. , Truly “plug and play,” Touchpoints are ...
(Date:6/20/2017)... ... 20, 2017 , ... Dr. Manju R. Kejriwal currently accepts ... whether or not they have a referral. Dr. Kejriwal offers state-of-the-art treatment through ... targets bacteria and damaged tissue without affecting the surrounding tissue. This technology virtually ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... With certifications ... Invisalign® in Denville, NJ, Drs. Adam and Hal Kimowitz are currently accepting new ... complications that traditional orthodontics can cause for some patients, which is why they offer ...
Breaking Medicine News(10 mins):